[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[S. 4152 Introduced in Senate (IS)]

<DOC>






117th CONGRESS
  2d Session
                                S. 4152

 To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the 
               Critical Path Public-Private Partnerships.


_______________________________________________________________________


                   IN THE SENATE OF THE UNITED STATES

                              May 5, 2022

  Mr. Kelly (for himself, Ms. Collins, and Ms. Sinema) introduced the 
 following bill; which was read twice and referred to the Committee on 
                 Health, Education, Labor, and Pensions

_______________________________________________________________________

                                 A BILL


 
 To amend the Federal Food, Drug, and Cosmetic Act to reauthorize the 
               Critical Path Public-Private Partnerships.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. REAUTHORIZATION OF THE CRITICAL PATH PUBLIC-PRIVATE 
              PARTNERSHIPS.

    Section 566(f) of the Federal Food, Drug, and Cosmetic Act (21 
U.S.C. 360bbb-5(f)) is amended by striking ``$6,000,000 for each of 
fiscal years 2018 through 2022'' and inserting ``$10,000,000 for each 
of fiscal years 2023 through 2027''.
                                 <all>